Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ki Hoon Han

Showing results (71-80 of 76) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 76 results.
Clinical Therapeutics|October 14, 2022
A Multicenter, Randomized, Double-blind, Active-controlled, Factorial Design, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Combination Therapy of Pitavastatin and Ezetimibe Versus Monotherapy of Pitavastatin in Patients With Primary HypercholesterolemiaHan Saem Jeong, Soon Jun Hong, Jin-Man Cho, et al.
Clinical Therapeutics|April 21, 2018
Efficacy and Safety of Fixed-dose Combination Therapy With Telmisartan and Rosuvastatin in Korean Patients With Hypertension and Dyslipidemia: TELSTA-YU (TELmisartan-rosuvaSTAtin from YUhan), a Multicenter, Randomized, 4-arm, Double-blind, Placebo-controlled, Phase III StudyGyu Chul Oh, Jung-Kyu Han, Ki Hoon Han, et al.
Clinical Therapeutics|December 11, 2017
Efficacy and Safety of Adding Omega-3 Fatty Acids in Statin-treated Patients with Residual Hypertriglyceridemia: ROMANTIC (Rosuvastatin-OMAcor iN residual hyperTrIglyCeridemia), a Randomized, Double-blind, and Placebo-controlled TrialChee Hae Kim, Kyung Ah Han, Jaemyung Yu, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|September 16, 2020
Efficacy and safety of co-administered telmisartan/amlodipine and rosuvastatin in subjects with hypertension and dyslipidemiaXuan Jin, Moo Hyun Kim, Ki Hoon Han, et al.
Clinical Therapeutics|June 8, 2026
Efficacy and Safety Profile of a Triple Single-Pill Combination of Valsartan/Amlodipine/Chlorthalidone in Patients with Uncontrolled HypertensionHae-Young Lee, Soon-Yong Suh, Ho-Joong Youn, et al.
The New England Journal of Medicine|March 17, 2010
Duration of dual antiplatelet therapy after implantation of drug-eluting stentsSeung-Jung Park, Duk-Woo Park, Young-Hak Kim, et al.
Pageof 8

Showing results (71-80 of 76) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 76 results.
Clinical Therapeutics|October 14, 2022
A Multicenter, Randomized, Double-blind, Active-controlled, Factorial Design, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Combination Therapy of Pitavastatin and Ezetimibe Versus Monotherapy of Pitavastatin in Patients With Primary HypercholesterolemiaHan Saem Jeong, Soon Jun Hong, Jin-Man Cho, et al.
Clinical Therapeutics|April 21, 2018
Efficacy and Safety of Fixed-dose Combination Therapy With Telmisartan and Rosuvastatin in Korean Patients With Hypertension and Dyslipidemia: TELSTA-YU (TELmisartan-rosuvaSTAtin from YUhan), a Multicenter, Randomized, 4-arm, Double-blind, Placebo-controlled, Phase III StudyGyu Chul Oh, Jung-Kyu Han, Ki Hoon Han, et al.
Clinical Therapeutics|December 11, 2017
Efficacy and Safety of Adding Omega-3 Fatty Acids in Statin-treated Patients with Residual Hypertriglyceridemia: ROMANTIC (Rosuvastatin-OMAcor iN residual hyperTrIglyCeridemia), a Randomized, Double-blind, and Placebo-controlled TrialChee Hae Kim, Kyung Ah Han, Jaemyung Yu, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|September 16, 2020
Efficacy and safety of co-administered telmisartan/amlodipine and rosuvastatin in subjects with hypertension and dyslipidemiaXuan Jin, Moo Hyun Kim, Ki Hoon Han, et al.
Clinical Therapeutics|June 8, 2026
Efficacy and Safety Profile of a Triple Single-Pill Combination of Valsartan/Amlodipine/Chlorthalidone in Patients with Uncontrolled HypertensionHae-Young Lee, Soon-Yong Suh, Ho-Joong Youn, et al.
The New England Journal of Medicine|March 17, 2010
Duration of dual antiplatelet therapy after implantation of drug-eluting stentsSeung-Jung Park, Duk-Woo Park, Young-Hak Kim, et al.
Pageof 8